The future of glioma treatment: stem cells, nanotechnology and personalized medicine

Maryam Rahman1, Brian Hoh, Nathan Kohler

  • 1Department of Neurosurgery, University of Florida, Box 100265, Gainesville, FL 32610, USA. maryam.rahman@neurosurgery.ufl.edu

Insights

Despite advances in treating central nervous system (CNS) tumors, outcomes remain poor. Personalized medicine, focusing on tumor phenotype and novel therapies like stem cells, offers new hope for brain cancer patients.

Area of Science:

  • Neuro-oncology
  • Cancer therapy
  • Molecular medicine

Background:

  • Central nervous system (CNS) tumors present a significant challenge in oncology.
  • Despite advancements in therapies and imaging, clinical outcomes for CNS malignancies remain dismal.
  • Diverse tumor subtypes necessitate individualized treatment approaches.

Purpose of the Study:

  • To review novel therapeutic strategies for brain tumors.
  • To highlight the importance of personalized medicine in CNS oncology.
  • To discuss emerging treatment options including stem cells, nanotechnology, and molecular medicine.

Main Methods:

  • Literature review of recent advancements in CNS tumor research.
  • Analysis of emerging therapeutic modalities.
  • Discussion of personalized medicine paradigms in neuro-oncology.

Main Results:

  • Novel therapies including stem cells, nanotechnology, and molecular medicine show promise.
  • Personalized medicine, based on tumor phenotype, is crucial for tailoring treatment.
  • Despite progress, significant challenges in improving patient outcomes persist.

Conclusions:

  • Personalized medicine and novel therapeutic strategies are essential for advancing brain tumor treatment.
  • Further research into stem cells, nanotechnology, and molecular medicine is warranted.
  • Tailoring therapy to individual tumor characteristics offers the best hope for improving patient outcomes in CNS malignancies.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...